...
首页> 外文期刊>BMJ Open >Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine
【24h】

Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine

机译:加拿大的个性化医学:肿瘤学,心脏病学和家庭医学的采用和实践调查

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction In order to provide baseline data on genetic testing as a key element of personalised medicine (PM), Canadian physicians were surveyed to determine roles, perceptions and experiences in this area. The survey measured attitudes, practice, observed benefits and impacts, and barriers to adoption. Methods A self-administered survey was provided to Canadian oncologists, cardiologists and family physicians and responses were obtained online, by mail or by fax. The survey was designed to be exploratory. Data were compared across specialties and geography. Results The overall response rate was 8.3%. Of the respondents, 43%, 30% and 27% were family physicians, cardiologists and oncologists, respectively. A strong majority of respondents agreed that genetic testing and PM can have a positive impact on their practice; however, only 51% agreed that there is sufficient evidence to order such tests. A low percentage of respondents felt that they were sufficiently informed and confident practicing in this area, although many reported that genetic tests they have ordered have benefited their patients. Half of the respondents agreed that genetic tests that would be useful in their practice are not readily available. A lack of practice guidelines, limited provider knowledge and lack of evidence-based clinical information were cited as the main barriers to practice. Differences across provinces were observed for measures relating to access to testing and the state of practice. Differences across specialties were observed for the state of practice, reported benefits and access to testing. Conclusions Canadian physicians recognise the benefits of genetic testing and PM; however, they lack the education, information and support needed to practice effectively in this area. Variability in practice and access to testing across specialties and across Canada was observed. These results support a need for national strategies and resources to facilitate physician knowledge, training and practice in PM.
机译:简介为了提供有关基因检测作为个性化医学(PM)关键要素的基线数据,对加拿大医生进行了调查,以确定其在该领域的作用,看法和经验。该调查测量了态度,实践,观察到的收益和影响以及采用的障碍。方法向加拿大的肿瘤科医生,心脏病专家和家庭医生提供了一项自我管理的调查,并通过在线,邮件或传真获得了答复。该调查旨在进行探索。比较了各个专业和地理位置的数据。结果总有效率8.3%。在受访者中,分别有43%,30%和27%是家庭医生,心脏病专家和肿瘤科医生。绝大多数受访者认为基因检测和PM可以对其实践产生积极影响;但是,只有51%的人同意有足够的证据下令进行此类测试。一小部分的受访者认为他们在这一领域有足够的知识和信心,尽管许多人报告说他们订购的基因检测使他们的患者受益。一半的受访者一致认为,目前尚无法进行对他们的实践有用的基因检测。缺乏实践指南,提供者知识有限以及缺乏循证医学信息是导致实践的主要障碍。观察到各省在获得测试和实践状况方面的差异。在实践状态,报告的收益和获得测试的机会方面,各专业之间存在差异。结论加拿大医生认识到基因检测和PM的好处。但是,他们缺乏在这一领域进行有效实践所需的教育,信息和支持。观察到实践中的差异以及跨专业和整个加拿大获得测试的机会。这些结果支持需要国家策略和资源来促进医师在PM中的知识,培训和实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号